Asia-pacific Sepsis Diagnostics Market Forecast 2021-2028

Asia-pacific Sepsis Diagnostics Market Forecast 2021-2028

The Asia-Pacific sepsis diagnostics market is anticipated to grow at a CAGR of 8.57% during the forecast period, 2021-2028. The factors driving the demand for sepsis diagnostics are the high mortality rates associated with the disease and the rising awareness regarding the diagnosis and treatment of sepsis.

Japan, China, India, Vietnam, Australia & New Zealand, Indonesia, South Korea, Thailand, and Rest of Asia-Pacific, are assessed for the Asia-Pacific sepsis diagnostics market growth analysis. The societal significance of developing high-quality guidelines for sepsis is high in Japan. It is also the dominant cause of admissions to intensive care units (ICUs), and deaths. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 is a set of clinical practice guidelines for sepsis and septic shock. Further, as per a 2018 study, the available treatments for sepsis and disseminated intravascular coagulation (DIC) diagnosis and treatment were common in Japanese clinical settings. Such factors are set to drive market growth in Japan.
In Australia, researchers have estimated that almost 5000 people die from sepsis every year, with 18,000 cases reaching the intensive care units of hospitals. Another survey by the George Institute revealed that only 40% of Australians have heard about the condition. Simultaneously, the burden of death due to sepsis is more than prostate, colorectal, or breast cancer. Also, sepsis incidences continue to rise in the country. Such factors have led to a team of experts initiating a nationwide campaign for raising public awareness about the 'time-critical medical emergency' of sepsis.

Some of the key players in the market are Luminex Corporation, Danaher, F. Hoffmann-La Roche, Thermo Fisher Scientific Inc, BioMérieux SA, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Prevailing Burden Of Sepsis
3.1.2. Complications Arising Due To Hospital-acquired Infections (Hais)
3.1.3. Spread Of Infectious Diseases Augmenting Sepsis Procedures
3.1.4. Surging Government Initiatives
3.2. Key Restraints
3.2.1. Complications Associated With The Reimbursement Policies
3.2.2. High Cost Of An Automated Diagnostics Instrument
4. Key Analytics
4.1. Impact Of Covid-19 On Sepsis Diagnostics Market
4.2. Key Investment Insights
4.3. Porter's Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
5. Market By Technology
5.1. Microbiology
5.2. Immunoassay
5.3. Molecular Diagnostics
5.4. Other Technologies
6. Market By Diagnostic Method
6.1. Conventional Diagnostics
6.2. Automated Diagnostics
7. Market By Product
7.1. Blood Culture Media
7.2. Assay Kits & Reagents
7.3. Instruments
8. Market By Pathogen
8.1. Gram - Positive And Gram - Negative Bacterial Sepsis
8.2. Fungal Sepsis
8.3. Other Pathogens
9. Market By Testing Type
9.1. Laboratory Testing
9.2. Point-of-care Testing
10. Geographical Analysis
10.1. Asia-pacific
10.1.1. Market Size & Estimates
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis China Japan Australia & New Zealand India South Korea Thailand Indonesia Vietnam Rest Of Asia-pacific
11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Mergers & Acquisitions
11.1.2. Product Launches & Developments
11.1.3. Partnerships, Contracts/Agreements & Collaborations
11.1.4. Business Expansions/ Approvals/ Announcements
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. Becton, Dickinson And Company
11.2.3. Biomerieux Sa
11.2.4. Bruker Corporation
11.2.5. Cytosorbents
11.2.6. Danaher
11.2.7. Ekf Diagnostics
11.2.8. F. Hoffmann-la Roche
11.2.9. Immunexpress Inc
11.2.10. Luminex Corporation
11.2.11. Response Biomedical Corporation
11.2.12. T2 Biosystems Inc
11.2.13. Thermo Fisher Scientific Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings